November 28, 2016

DS Biopharma to present at Piper Jaffray 28th Annual Healthcare Conference

Dublin, Ireland, 28th November, 2016: DS Biopharma (DS), a privately held drug discovery and development company, today announced that it will present an overview of the […]
September 29, 2016

DS Biopharma will today present data on a Phase IIa study at the European Academy of Dermatology and Venereology (EADV) Congress

Dublin, Ireland, 29th September 2016: DS Biopharma (DS) will today present data on their Phase IIa study with DS107 for the treatment of atopic dermatitis at […]
August 23, 2016

DS Biopharma (DS) Announces Spin-Out Company Focused on Fibrotic Conditions and Pulmonary Disorders

Dublin, Ireland, 22 August 2016: DS Biopharma (DS), a privately held drug discovery and development company with industry-leading expertise in lipid science, today announces the launch […]
January 7, 2016

DS Biopharma announces positive top-line Phase IIa trial results for DS107 as an oral treatment for moderate to severe atopic dermatitis

Dublin, Ireland, January 7th, 2016 – DS Biopharma (DS), a privately held biopharmaceutical company, today announced positive top-line results from a Phase IIa clinical trial of […]
September 25, 2015

DS Biopharma appoints Leopoldo Zambeletti as Non-Executive Director

Dublin, Ireland, September 25, 2015 – DS Biopharma, a privately held biopharmaceutical company, today announced the appointment of Leopoldo Zambeletti as a Non-Executive Director to the […]